Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer
Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of AZD4547
compared with paclitaxel in patients with advanced gastric or lower-oesophageal cancer whose
tumours are found to have FGFR2 polysomy or gene amplification.